Agonist and Antagonist Actions of Buprenorphine on Three Types of Opioid Receptor in Isolated Preparations
Open Access
- 1 January 1986
- journal article
- research article
- Published by Elsevier BV in The Japanese Journal of Pharmacology
- Vol. 40 (1), 95-101
- https://doi.org/10.1254/jjp.40.95
Abstract
Both agonist and antagonist actions of buprenorphine on isolated preparations were studied. The Ke (equilibrium dissociation constant) values of both naloxone and Mr 2266 [(-)-2-(3-furylmethyl)-5, 9-diethyl-2'-hydroxy-6, 7-henzomorphan] against buprenorphine and the ratio of IC50 (concentration of the drug to produce 50% inhibition of the twitch) value of buprenorphine after to before exposure of mouse vas deferens to β-FNA (β-fumaramate methyl ester derivatives of naltrexone), an irreversible mu antagonist, suggest that buprenorphine acts as both a mu and kappa agonist on mouse vas deferens. The agonist effect of buprenorphine at relatively high doses on guinea-pig ileum and mouse vas deferens and the negative agonist effect on both rat and rabbit vas deferens indicate that buprenorphine acts as a partial agonist on isolated preparations. The Ke values of buprenorphine show that buprenorphine has about equal antagonist effectiveness against a mu and kappa agonist with approximately five-fold lower effectiveness against a delta agonist. The possible mechanisms for the several characteristic actions of buprenorphine on guinea-pig ileum such as the slow onset of action, the increased magnitude of inhibition after washing the tissue, the negative elimination of the inhibition by either washing the tissue or the naloxone administration, and the negative elimination of the antagonist action by washing the tissue were discussed.This publication has 9 references indexed in Scilit:
- The choice of opiate receptor subtype by neo-endorphinsEuropean Journal of Pharmacology, 1982
- Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptorsEuropean Journal of Pharmacology, 1982
- In vivo RECEPTOR BINDING OF THE OPIATE PARTIAL AGONIST, BUPRENORPHINE, CORRELATED WITH ITS AGONISTIC AND ANTAGONISTIC ACTIONSBritish Journal of Pharmacology, 1981
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- A CLASSIFICATION OF OPIATE RECEPTORS THAT MEDIATE ANTINOCICEPTION IN ANIMALSBritish Journal of Pharmacology, 1980
- Human Pharmacology and Abuse Potential of the Analgesic BuprenorphineArchives of General Psychiatry, 1978
- AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENTBritish Journal of Pharmacology, 1977
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- EFFECTS OF MORPHINE-LIKE AND NALORPHINE-LIKE DRUGS IN NONDEPENDENT AND MORPHINE-DEPENDENT CHRONIC SPINAL DOG1976